期刊文献+

颈动脉斑块患者服用他汀药物对肾功能的影响

Effects of Stains on Renal Function in Patients with Carotid Artery Plaque
下载PDF
导出
摘要 目的:探讨他汀类药物对颈动脉斑块患者肾功能的影响。方法:120例颈动脉斑块患者按服用他汀类药物种类随机分为4组,每组30例,A组阿托伐他汀10mg/d,B组辛伐他汀20mg/d,C组瑞舒伐他汀5mg/d,D组洛伐他汀20mg/d。测定治疗前后血脂、肾功能及高敏C反应蛋白(hs-CRP)。结果:服药4周及15周后,患者的总胆固醇、血甘油三酯、低密度脂蛋白胆固醇、胱抑素C、hsCRP水平较服药前明显降低(P<0.05),高密度脂蛋白胆固醇明显增高(P<0.05),尿素氮较服药前无明显降低(P>0.05);服药15周后,肌酐较服药前明显降低(P<0.05)。四组间比较差异无统计学意义(P>0.05)。结论:颈动脉斑块患者常规他汀类药物可降低血脂及炎症因子水平,对肾功能有保护作用。 Objective: To investigate the effects of statins on renal function in patients with plaque of carotid artery.Methods: 120 cases of patients with carotid atherosclerotic plaque by taking a statin drug kinds were randomly divided into 4 groups,30 cases in each group,a group of atorvastatin 10mg/d,simvastatin 20mg/d in group B,group C rosuvastatin cutting atorvastatin 5mg/d,D group lovastatin 20 mg.Determination of renal function and blood lipid and high sensitive C reactive protein(hs-CRP) before and after treatment.Results: Medication after 4 weeks and 15 weeks,serum total cholesterol,triglyceride,low density fat cholesterol,Cystatin C and hs-CRP levels than those before treatment decreased significantly(P〈0.05),high density lipoprotein cholesterol was significantly higher(P〈0.05),blood urea nitrogen(BUN) compared with those before taking no decreased significantly(P〈0.05); after 15 weeks of dosing,creatinine than before treatment decreased significantly(P〈0.05).There was no significant difference between the four groups(P〈0.05).Conclusion: Carotid plaques in patients with conventional statins can reduce blood lipids and inflammatory factors,have protective effects on renal function.
出处 《中国医药导刊》 2016年第4期373-374,376,共3页 Chinese Journal of Medicinal Guide
基金 河北省科技支撑计划(项目编号:12277769) 课题名称:石家庄市体检人群心血管疾病危险因素和诊疗现状调查研究
关键词 颈动脉斑块 他汀类药物 肾功能 胱抑素C 高敏C反应蛋白 Carotid atherosclerotic plague Stains Renal Function Cystatin C High sensitive C reactive protein
  • 相关文献

参考文献15

  • 1周云辙,李嘉民,花爱辉,张世英,李震中.纤溶系统与颈动脉粥样硬化关系的研究[J].河北医药,2011,33(6):851-853. 被引量:2
  • 2Flaherty M L, Kissela B, Khoury J C, et al. Carotid artery stenosis as a cause ofstroke[J]. Neuroepidemiology,2013,40(1):36-41.
  • 3Nadel J, Hewitt T, Horton D,et al.Acute coronary syndrome in Australia: Whereare we now and where are we going- [J]. Australas Med J,2014,7(3):149-156.
  • 4郭万学.超声医学[M].第6版.北京:人民军医出版社,2012:689-760.
  • 5Chen Y,Arnal-Levron M,LagardeM,et al. HP1 macrophages oxidizedcholesterol, generating 7-derivative oxysterols specifically released by HDL[J].Steroids,2015,99(Part B):212-218.
  • 6Marais AD, Kim JB, Wasserman SM, et al.PCSK9 inhibition in LDL cholesterolreduction: Genetics and therapeutic implications of very low plasmalipoproteinlevels [J].Pharmacology and Therapeutics,2015,145:58-66.
  • 7Baigent C, Landray M J, Reith C, et al. The effects of lowering LDL cholesterolwith simvastatin plus ezetimibe in patients with chronic kidney disease (Studyof Heart and Renal Protection): a randomised placebo-controlled trial[J].TheLancet,2011,377(9784):2181-2192.
  • 8shiyama K,Sato T,Taguma Y.Low-Density Lipoprotein Apheresis AmelioratesRenal Prognosis of Cholesterol Crystal Embolism[J].Therapeutic Apheresis andDialysis,2015,19(4):355-360.
  • 9孟梅霞,张莉,傅艳平,畅飞,赵瑾,张媛.慢性肾脏病与血脂异常关系的调查研究[J].陕西医学杂志,2014,43(9):1157-1159. 被引量:11
  • 10Ge S, Hertel B, Koltsova E K, et al. Increased Atherosclerotic Lesion Formation andVascular Leukocyte Accumulation in Renal Impairment Are Mediated by Interleukin-17A/Novelty and Significance[J]. Circulation Research,2013,113(8):965-974.

二级参考文献25

  • 1张路霞,左力,徐国宾,王芳,王淑玉,王梅,吕继成,张军茹,刘力生,王海燕.北京市石景山地区中老年人群中慢性肾脏病的流行病学研究[J].中华肾脏病杂志,2006,22(2):67-71. 被引量:369
  • 2马淑梅,李铁军,耿宁,邹德玲,李晓东,孙英贤,水野杏一.控制危险因素对无症状性冠状动脉内膜病变防治的研究[J].中国实用内科杂志:临床前沿版,2006,26(8):1248-1251. 被引量:5
  • 3周永昌.超声医学第3版[M].北京:科学技术文献出版社,2001.1004-1005.
  • 4朱忠勇主编.实用医学检验学.第1版,人民卫生出版社,1992.120.
  • 5Hegele RA. The pathogenesis of atherosclerosis. Clin Chem Acta, 1996, 246:21-38.
  • 6Salomaa V, Stinson V, Kark JD, et al. Association of fibrinolytic parameters with early atherosclerosis. Circulation, 1995,91:284-90.
  • 7Oseroff A, Krishnamurti C, Hassett A, et al. Plasminogen activator and plasminogen activator inhibitor activities in men with coronary artery disease. J Lab Clin Med, 1989, 113:88.
  • 8Mehta J, Mehta P, Lawson D, et al. Plasma tissue plasmino -gen activator inhibitor levels in coronary artery disease:correlation with age and serum triglyeeride concen-trations. J Am Coil Cardial, 1987,19:263.
  • 9Zalewski A, Shi Y, Nardone D, et al. Evidence for reduced fibrinolytic activity in unstable angina at rest. Clinical biochemical and angiographic correlates. Circulation, 1991,83 : 1685.
  • 10Thompson SG,van de Loo LCW. ECAT angina pectoris study:Baseline associations of haemostatic factors with extent of coronary arteriosclerosis and other coronary risk factors in 3000 patients with angina peetoris undergoing coronary angiography. Eur Heart J, 1993,14 : 8.

共引文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部